Advertisement
UK markets open in 4 hours 18 minutes

  • NIKKEI 225

    36,811.88
    -1,267.82 (-3.33%)
     

  • HANG SENG

    16,146.26
    -239.61 (-1.46%)
     

  • CRUDE OIL

    86.00
    +3.27 (+3.95%)
     

  • GOLD FUTURES

    2,423.30
    +25.30 (+1.06%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • Bitcoin GBP

    48,580.86
    -1,185.30 (-2.38%)
     

  • CMC Crypto 200

    1,246.44
    +360.90 (+37.97%)
     

  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     

  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     
Money:

Best mortgage deals of the week

As possibility of multiple interest rate cuts dwindle here's what banks and building societies are offering

Arrowhead Pharma Heads Down Midday After Downgrade

Investing.com

Investing.com - Arrowhead Pharmaceuticals took a tumble midday Friday following a research downgrade that argued the stock is now fairly valued.

Arrowhead (NASDAQ:ARWR) shares sank about 6%.

Cantor Fitzgerald cut the stock to neutral from overweight, leaving its price target at $24.

It’s time for shares to take a breather after a two-rally that’s seen the stock rocket about 1,700% higher, Cantor Fitzgerald argued.

Last month the stock was added to the S&P 600 Small Cap.

Related Articles

Apple moves Mac Pro production to China from U.S.: WSJ

U.S. lags in export financing arms race fueled by China: EXIM report

Singapore to allow virtual banks as part of move to open up market